MedPath

ANGIOMAX

ANGIOMAX

Approved
DIN Number

02246533

Drug Class

Human

Market Date

May 8, 2003

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02246533
AIG Number0148342001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
B01AE06 BIVALIRUDIN
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification20:12.04.12
Health Canada Classification

ACTIVE INGREDIENTS (1)

BIVALIRUDINActive
Strength: 250 MG / VIAL
Monograph: BIVALIRUDIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.